PROGRAM OVERVIEW

Sleep disorders are highly prevalent in society today and are often inadequately treated, resulting in significant morbidity and mortality. An estimated 70 million Americans experience sleep disorders, and direct medical costs associated with doctor visits, hospital services, prescriptions, and over-the-counter medications are estimated to be in the hundreds of billions of dollars each year. Data have shown that roughly two-thirds of survey respondents experienced a sleep problem at least a few nights a week during the previous month, and nearly half experienced difficulty with sleep every night or almost every night.

Effective management and treatment of sleep disorders are often associated with distinct challenges for healthcare practitioners since there are noticeable gaps in clinical knowledge of neurobiology, epidemiology, comorbid conditions, adherence, and other aspects of successful treatment. Further, the cumulative long-term effects of sleep deprivation and sleep disorders have been associated with a wide range of damaging health consequences such as hypertension, diabetes, obesity, depression, heart attack and stroke. As a result, healthcare providers must be made more aware of these disorders with the end goal of improving patient care.

All healthcare providers managing sleep disorders must have an acute knowledge of how to recognize, diagnose and manage sleep problems due to their tendency toward chronicity and the association of sleep disorders with increased morbidity and poorer outcomes. Despite numerous obstacles to diagnosis and treatment, physicians need to take the time to discuss sleep habits with their patients and include comprehensive assessments in patient histories. The purpose of this sleep program is to provide clinicians with relevant information in several areas of sleep disorders, including (1) the neurobiology of sleep disorders, particularly in order to improve the diagnosis and treatment; (2) comorbid conditions associated with sleep disorders; and (3) the importance of individualized treatment plans and collaboration with other providers. By tackling these areas of need, healthcare providers can positively affect the lives of their patients through timely recognition and management of sleep disorders.

Earn CME Credit for this Activity.
1.0 AMA PRA Category 1 Credits

Register Now!

RELEASE DATE: 6/27/2013

EXPIRATION DATE: 6/26/2014

MEDIUM: Internet

OBJECTIVES

After completion of this activity, participant should be able to:

  • Review the neurobiology of sleep disorders in order to improve the diagnosis and treatment of patients with sleep disorders
  • Identify comorbid conditions associated with sleep disorders in order to improve treatment of patients
  • Develop individualized treatment plans for patients with sleep disorders by improving collaboration with other sleep professionals

TARGET AUDIENCE

This activity has been designed to meet the educational needs of primary care physicians, other healthcare professionals who diagnose and treat patients with sleep disorders.



 

Faculty

  • Sanford H. Auerbach, MD
    Activity Director/Moderator

    Associate Professor Department of Neurology
    Boston University School of Medicine
    Director, Sleep Disorders Center
    Boston Medical Center
    Boston, MA

  • Karl Doghramji, MD
    Panelist

    Professor, of Psychiatry, Neurology and Medicine
    Medical Director, Jefferson Sleep Disorder Center
    Program Director, Fellowship in Sleep Medicine
    Thomas Jefferson University
    Philadelphia, PA

  • David Neubauer, MD
    Panelist

    Associate Professor
    Department of Psychiatry
    Johns Hopkins University School of Medicine
    Associate Director
    Johns Hopkins Sleep Disorders Center
    John Hopkins Bayview Medical Center
    Baltimore, MD

 

CME ADVISORY COMMITTEE

Course Reviewer

Katherine Galluzzi, DO, CMD, FACOFP dist.
Professor and Chairperson, Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Attending Physician, Family Medicine
Tenet Roxborough Memorial Hospital
Philadelphia, PA

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor.  All faculty, authors, editors, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Faculty
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: 

Sanford H. Auerbach, MD
Disclosure: Dr. Auerbach has no relevant financial relationships to disclose.

Karl Doghramji, MD
Disclosure: Dr. Doghramji has an ownership interest in Merck & Co., Inc.  He receives consulting fees from Jazz Pharmaceuticals, Teva Pharmaceuticals Industries, Ltd., UCB, Inc., and Vanda Pharmaceuticals, Inc.

David Neubauer, MD
Disclosure: Dr. Neubauer has no relevant financial relationships to disclose.

Katherine Galluzzi, DO, CMD, FACOFP dist.
Disclosure: Dr. Galluzzi has no relevant financial relationships to disclose.

Planning Committee
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Kelly Kraines of Med Learning Group has no relevant financial relationships to disclose.

Christopher Drury of The Quill Consulting has no relevant financial relationships to disclose.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com. Contact this CME provider for privacy and confidentiality policy statement information at:
http://www.medlearninggroup.com/privacy-policy/

COURSE VIEWING REQUIREMENTS

PC
Internet Explorer (v6 or greater), or Firefox

MAC
Safari

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

TO OBTAIN CME CREDITS:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the post-test and activity evaluation.
  • Physicians who successfully complete the post-test and evaluation will receive CME credit.
  • You must score 70% or higher on the post-test to receive credit for this activity.
  • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

DISCLOSURE OF UNLABLED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

ACKNOWLEDGEMENT

This activity is sponsored by Med Learning Group.

UMA

This activity is supported by an educational grant from Purdue Pharma L.P.

Teva

If you have any questions regarding this activity, send an email to info@medlearninggroup.com.

This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields.  

Copyright © 2013 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Earn CME Credit for this Activity.
1.0 AMA PRA Category 1 Credits

Register Now!